CERo Therapeutics Holdings, Inc.
CERO
$9.46
$0.232.49%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 59.99% | -3.78% | -7.32% | -20.60% | 201.88% |
Total Receivables | -- | -- | -- | -46.08% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 105.50% | -17.83% | -34.64% | -31.43% | 102.28% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 55.30% | -0.01% | -12.52% | -22.82% | 179.25% |
|
|||||
Total Current Assets | 55.30% | -0.01% | -12.52% | -22.82% | 179.25% |
Net Property, Plant & Equipment | -13.52% | -12.50% | -11.55% | -10.22% | -9.13% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | -9.09% | -19.51% | -- |
Total Assets | 28.75% | -4.39% | -11.92% | -18.58% | 76.59% |
|
|||||
Total Accounts Payable | 41.53% | -32.39% | 5.04% | -10.09% | 322.31% |
Total Accrued Expenses | -75.45% | 13.04% | 46.22% | 293.31% | 103.53% |
Short-term Debt | -- | -- | -59.60% | -37.09% | -32.88% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.26% | -5.86% | 13.36% | 3.32% | 3.35% |
Total Finance Division Other Current Liabilities | 0.00% | 251.67% | -85.00% | -93.55% | 862.73% |
Total Other Current Liabilities | 0.00% | 251.67% | -85.00% | -93.55% | 862.73% |
Total Current Liabilities | 6.17% | -21.44% | 7.33% | -24.65% | 232.21% |
|
|||||
Total Current Liabilities | 6.17% | -21.44% | 7.33% | -24.65% | 232.21% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -59.60% | -37.09% | -32.88% |
Capital Leases | -33.97% | -9.38% | -28.12% | -21.46% | -13.26% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.71% | -20.53% | 3.47% | -24.40% | 156.40% |
|
|||||
Common Stock & APIC | 9.24% | 1.15% | 15.17% | 6.74% | 5,131.68% |
Retained Earnings | -7.20% | 0.94% | -6.28% | -3.77% | -50.65% |
Treasury Stock & Other | 93.92% | 37.53% | 5.53% | 12.20% | -- |
Total Common Equity | 45.63% | 30.39% | 38.89% | 11.14% | 68.10% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -23.57% | -11.34% | -62.05% | 0.02% | -77.58% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -23.57% | -11.34% | -62.05% | 0.02% | -77.58% |
|
|||||
Total Common Equity | 45.63% | 30.39% | 38.89% | 11.14% | 68.10% |
Total Preferred Equity | -23.57% | -11.34% | -62.05% | 0.02% | -77.58% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 82.61% | 48.83% | -49.18% | 37.63% | -9,226.38% |
|